logo
Select company
Select metric
3.96%Cash to Assets Ratio
VS
Market
31
Sector
9
Industry
3
History
3
$ 3.44Close
$ 2.37 - $ 5.3 52-Week Range
Ticker Information

Ticker

ELDN

Company Name

ELEDON PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ELEDON PHARMACEUTICALS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ELDN - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 144.91M$ 5.74M3.96%
3/31/2025$ 161.31M$ 8.5M5.27%
12/31/2024$ 177.41M$ 20.55M11.58%
9/30/2024$ 114.58M$ 6.75M5.89%
6/30/2024$ 120.48M$ 26.04M21.61%
3/31/2024$ 80.82M$ 5.66M7%
12/31/2023$ 89.07M$ 4.61M5.18%
9/30/2023$ 96.07M$ 3.67M3.82%
6/30/2023$ 106.78M$ 40.95M38.35%
3/31/2023$ 82.31M$ 46.48M56.48%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ELEDON PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 114.46M ] / Assets [ $ 192.59M ]
(=) Cash to Assets [ 59.44% ]

ELDN - Cash to Assets Ratio, Last 5 years

3.82%

Minimum

Sep 30, 2023

60.79%

Maximum

Dec 31, 2022

34.44%

Average

44.8%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.92%
average9.84%
median6.44%
std9.62%